Market closed
NRX Pharmaceuticals Inc./$NRXP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Ticker
$NRXP
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
-
ISIN
US6294442099
Website
NRXP Metrics
BasicAdvanced
$35M
-
-$2.36
1.22
-
Price and volume
Market cap
$35M
Beta
1.22
52-week high
$2.46
52-week low
$1.58
Average daily volume
124K
Financial strength
Current ratio
0.151
Quick ratio
0.066
Long term debt to equity
-21.578
Total debt to equity
-26.943
Interest coverage (TTM)
-85.67%
Management effectiveness
Return on assets (TTM)
-224.60%
Return on equity (TTM)
143.76%
Valuation
Price to book
-1.28
Price to tangible book (TTM)
-1.28
Price to free cash flow (TTM)
-2.041
Growth
Earnings per share change (TTM)
-40.70%
3-year earnings per share growth (CAGR)
-68.34%
NRXP News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for NRX Pharmaceuticals Inc. stock?
NRX Pharmaceuticals Inc. (NRXP) has a market cap of $35M as of May 12, 2025.
What is the P/E ratio for NRX Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for NRX Pharmaceuticals Inc. (NRXP) stock is 0 as of May 12, 2025.
Does NRX Pharmaceuticals Inc. stock pay dividends?
No, NRX Pharmaceuticals Inc. (NRXP) stock does not pay dividends to its shareholders as of May 12, 2025.
When is the next NRX Pharmaceuticals Inc. dividend payment date?
NRX Pharmaceuticals Inc. (NRXP) stock does not pay dividends to its shareholders.
What is the beta indicator for NRX Pharmaceuticals Inc.?
NRX Pharmaceuticals Inc. (NRXP) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.